Literature DB >> 25309978

Screening for cognitive impairment in a Chinese ALS population.

Qianqian Wei1, Xueping Chen, Zhenzhen Zheng, Rui Huang, Xiaoyan Guo, Bei Cao, Thomas H Bak, Huifang Shang.   

Abstract

Despite growing interest in cognitive impairment of ALS patients, there are only limited studies available that characterize cognitive deficits in the Chinese ALS population through highly sensitive and specific screening tools. The Chinese version of the Addenbrooke's Cognitive Examination-revised (ACE-R) and mini-mental state examination (MMSE) were applied to evaluate cognitive function in 145 sporadic ALS patients and 50 healthy controls. The mean onset age was 50.72 ± 12.38 years. Results showed that the prevalence of cognitive deficits was 14.48% and 30.34% based on the MMSE and ACE-R, respectively. Patients had a broad range of cognitive impairment domains, including language (26.21%), orientation/attention (24.13%), visuospatial ability (24.13%), memory (23.45%) and verbal fluency (22.76%). Logistic regression indicated that older age of onset, female gender and lower educational levels were potential determinants of cognitive deficits in ALS. Multiple regression analyses showed that the cognitive deficit during the baseline visit was not associated with the progression rate of ALS. In conclusion, cognitive impairment is common in Chinese ALS patients, but does not necessarily worsen the progression of ALS. ACE-R is superior to MMSE in detecting deficits in patients. Cognitive impairment in ALS patients may relate to age of onset, female gender and lower education level.

Entities:  

Keywords:  Addenbrooke’s Cognitive Examination-revised; Amyotrophic lateral sclerosis; cognitive impairment; cognitive screening; mini-mental state examination

Mesh:

Year:  2014        PMID: 25309978     DOI: 10.3109/21678421.2014.966311

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  15 in total

1.  Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis.

Authors:  QingQing Zhou; YongPing Chen; QianQian Wei; Bei Cao; Ying Wu; Bi Zhao; RuWei Ou; Jing Yang; XuePing Chen; Shinji Hadano; Hui-Fang Shang
Journal:  Mol Neurobiol       Date:  2016-04-07       Impact factor: 5.590

2.  Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study.

Authors:  Jürgen Keller; Martin Gorges; Hannah T Horn; Helena E A Aho-Özhan; Elmar H Pinkhardt; Ingo Uttner; Jan Kassubek; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

3.  Determining the Effect of the HNMT, STK39, and NMD3 Polymorphisms on the Incidence of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Multiple System Atrophy in Chinese Populations.

Authors:  Yongping Chen; Bei Cao; Ruwei Ou; Qianqian Wei; Xueping Chen; Bi Zhao; Ying Wu; Wei Song; Hui-Fang Shang
Journal:  J Mol Neurosci       Date:  2018-03-21       Impact factor: 3.444

4.  Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson's disease.

Authors:  Kazuya Kawabata; Hirohisa Watanabe; Kazuhiro Hara; Epifanio Bagarinao; Noritaka Yoneyama; Aya Ogura; Kazunori Imai; Michihito Masuda; Takamasa Yokoi; Reiko Ohdake; Yasuhiro Tanaka; Takashi Tsuboi; Tomohiko Nakamura; Masaaki Hirayama; Mizuki Ito; Naoki Atsuta; Satoshi Maesawa; Shinji Naganawa; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

5.  Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.

Authors:  Qian-Qian Wei; Yanbing Hou; Yongping Chen; Ruwei Ou; Bei Cao; Lingyu Zhang; Tianmi Yang; Huifang Shang
Journal:  Health Qual Life Outcomes       Date:  2021-07-20       Impact factor: 3.186

6.  The Global Cognition, Frontal Lobe Dysfunction and Behavior Changes in Chinese Patients with Multiple System Atrophy.

Authors:  Bei Cao; Bi Zhao; Qian-Qian Wei; Ke Chen; Jing Yang; RuWei Ou; Ying Wu; Hui-Fang Shang
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

7.  The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese Amyotrophic Lateral Sclerosis Population.

Authors:  Shan Ye; Ying Ji; Chengyu Li; Ji He; Xiaolu Liu; Dongsheng Fan
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

8.  Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival.

Authors:  Qian-Qian Wei; Yongping Chen; Bei Cao; Ru Wei Ou; Lingyu Zhang; Yanbing Hou; Xiang Gao; Huifang Shang
Journal:  Mol Neurodegener       Date:  2017-09-21       Impact factor: 14.195

9.  Screening for Cognitive Function in Complete Immobility Using Brain-Machine Interfaces: A Proof of Principle Study.

Authors:  Dorothée Lulé; Katharina Hörner; Cynthia Vazquez; Helena Aho-Özhan; Jürgen Keller; Martin Gorges; Ingo Uttner; Albert C Ludolph
Journal:  Front Neurosci       Date:  2018-08-15       Impact factor: 4.677

10.  Cognitive Impairment in Chinese Patients with Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Bo Cui; Liying Cui; Jing Gao; Mingsheng Liu; Xiaoguang Li; Caiyan Liu; Junfang Ma; Jia Fang
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.